Protalix BioTherapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PLX and other ETFs, options, and stocks.About PLX
Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11.
CEODror Bashan
CEODror Bashan
Employees213
Employees213
HeadquartersHackensack, New Jersey
HeadquartersHackensack, New Jersey
Founded1993
Founded1993
Employees213
Employees213
PLX Key Statistics
Market cap143.15M
Market cap143.15M
Price-Earnings ratio25.47
Price-Earnings ratio25.47
Dividend yield—
Dividend yield—
Average volume631.31K
Average volume631.31K
High today—
High today—
Low today—
Low today—
Open price$1.79
Open price$1.79
Volume0.00
Volume0.00
52 Week high$3.10
52 Week high$3.10
52 Week low$1.32
52 Week low$1.32
Stock Snapshot
With a market cap of 143.15M, Protalix BioTherapeutics(PLX) trades at $1.76. The stock has a price-to-earnings ratio of 25.47.
On 2026-01-08, Protalix BioTherapeutics(PLX) stock opened at $1.79, reached a high of —, and a low of —.
Protalix BioTherapeutics(PLX) shares are trading with a volume of 0, against a daily average of 631.31K.
In the last year, Protalix BioTherapeutics(PLX) shares hit a 52-week high of $3.10 and a 52-week low of $1.32.
In the last year, Protalix BioTherapeutics(PLX) shares hit a 52-week high of $3.10 and a 52-week low of $1.32.
People also own
Based on the portfolios of people who own PLX. This list is generated using Robinhood data, and it’s not a recommendation.